Literature DB >> 25824905

DOCK6 mutations are responsible for a distinct autosomal-recessive variant of Adams-Oliver syndrome associated with brain and eye anomalies.

Maja Sukalo1, Felix Tilsen1, Hülya Kayserili2,3, Dietmar Müller4, Beyhan Tüysüz5, Deborah M Ruddy6, Emma Wakeling7, Karen Helene Ørstavik8, Katie M Snape9, Richard Trembath6,10, Maryse De Smedt11, Nathalie van der Aa12, Martin Skalej13, Stefan Mundlos14, Wim Wuyts12,15, Laura Southgate10,16, Martin Zenker1.   

Abstract

Adams-Oliver syndrome (AOS) is characterized by the association of aplasia cutis congenita with terminal transverse limb defects, often accompanied by additional cardiovascular or neurological features. Both autosomal-dominant and autosomal-recessive disease transmission have been observed, with recent gene discoveries indicating extensive genetic heterogeneity. Mutations of the DOCK6 gene were first described in autosomal-recessive cases of AOS and only five DOCK6-related families have been reported to date. Recently, a second type of autosomal-recessive AOS has been attributed to EOGT mutations in three consanguineous families. Here, we describe the identification of 13 DOCK6 mutations, the majority of which are novel, across 10 unrelated individuals from a large cohort comprising 47 sporadic cases and 31 AOS pedigrees suggestive of autosomal-recessive inheritance. DOCK6 mutations were strongly associated with structural brain abnormalities, ocular anomalies, and intellectual disability, thus suggesting that DOCK6-linked disease represents a variant of AOS with a particularly poor prognosis.
© 2015 WILEY PERIODICALS, INC.

Entities:  

Keywords:  AOS; Adams-Oliver syndrome; DOCK6; brain anomalies; eye anomalies

Mesh:

Substances:

Year:  2015        PMID: 25824905     DOI: 10.1002/humu.22795

Source DB:  PubMed          Journal:  Hum Mutat        ISSN: 1059-7794            Impact factor:   4.878


  9 in total

1.  Adams-Oliver syndrome associated with gastrointestinal malformations.

Authors:  Lisa van Geyzel; Caroline Gribbon; Sarah Bradley; Donovan Duffy
Journal:  BMJ Case Rep       Date:  2016-11-25

2.  Heterozygous Loss-of-Function Mutations in DLL4 Cause Adams-Oliver Syndrome.

Authors:  Josephina A N Meester; Laura Southgate; Anna-Barbara Stittrich; Hanka Venselaar; Sander J A Beekmans; Nicolette den Hollander; Emilia K Bijlsma; Appolonia Helderman-van den Enden; Joke B G M Verheij; Gustavo Glusman; Jared C Roach; Anna Lehman; Millan S Patel; Bert B A de Vries; Claudia Ruivenkamp; Peter Itin; Katrina Prescott; Sheila Clarke; Richard Trembath; Martin Zenker; Maja Sukalo; Lut Van Laer; Bart Loeys; Wim Wuyts
Journal:  Am J Hum Genet       Date:  2015-08-20       Impact factor: 11.025

3.  Mechanism of cell-intrinsic adaptation to Adams-Oliver Syndrome gene DOCK6 disruption highlights ubiquitin-like modifier ISG15 as a regulator of RHO GTPases.

Authors:  Berati Cerikan; Elmar Schiebel
Journal:  Small GTPases       Date:  2017-03-13

4.  DOCK3-related neurodevelopmental syndrome: Biallelic intragenic deletion of DOCK3 in a boy with developmental delay and hypotonia.

Authors:  Aiko Iwata-Otsubo; Alyssa L Ritter; Brooke Weckselbatt; Nicole R Ryan; David Burgess; Laura K Conlin; Kosuke Izumi
Journal:  Am J Med Genet A       Date:  2017-11-12       Impact factor: 2.802

Review 5.  The DOCK protein family in vascular development and disease.

Authors:  Clare E Benson; Laura Southgate
Journal:  Angiogenesis       Date:  2021-02-06       Impact factor: 10.658

6.  CdGAP/ARHGAP31, a Cdc42/Rac1 GTPase regulator, is critical for vascular development and VEGF-mediated angiogenesis.

Authors:  Christine Caron; Jonathan DeGeer; Patrick Fournier; Philippe M Duquette; Vilayphone Luangrath; Hidetaka Ishii; Fereshteh Karimzadeh; Nathalie Lamarche-Vane; Isabelle Royal
Journal:  Sci Rep       Date:  2016-06-07       Impact factor: 4.379

Review 7.  The Molecular Basis of Human Anophthalmia and Microphthalmia.

Authors:  Philippa Harding; Mariya Moosajee
Journal:  J Dev Biol       Date:  2019-08-14

Review 8.  Relevance of Notch Signaling for Bone Metabolism and Regeneration.

Authors:  Tobias M Ballhause; Shan Jiang; Anke Baranowsky; Sabine Brandt; Peter R Mertens; Karl-Heinz Frosch; Timur Yorgan; Johannes Keller
Journal:  Int J Mol Sci       Date:  2021-01-29       Impact factor: 5.923

Review 9.  RHO to the DOCK for GDP disembarking: Structural insights into the DOCK GTPase nucleotide exchange factors.

Authors:  Andrew P Thompson; Christina Bitsina; Janine L Gray; Frank von Delft; Paul E Brennan
Journal:  J Biol Chem       Date:  2021-03-05       Impact factor: 5.157

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.